Improving the efficacy of renal cell carcinoma immunotherapy by combining anti-PD-1 and anti-CD47 immune checkpoints

Project Details

AcronymCOMBO KD II (Action Lions Vaincre le cancer-2019)
StatusFinished
Effective start/end date1/01/2030/06/22

Funding

  • Action LIONS Vaincre le Cancer: €50,000.00